End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 MYR | -1.82% | -15.62% | -33.33% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 403.5 |
Enterprise Value (EV) 1 | 390.7 |
P/E ratio | 144 x |
Yield | - |
Capitalization / Revenue | 5.96 x |
EV / Revenue | 5.77 x |
EV / EBITDA | 47.2 x |
EV / FCF | -50,390,820 x |
FCF Yield | -0% |
Price to Book | 6.27 x |
Nbr of stocks (in thousands) | 996,300 |
Reference price 2 | 0.4050 |
Announcement Date | 4/30/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 12.21 | 14.45 | 25.48 | 51.96 | 67.7 |
EBITDA 1 | 2.017 | 3.249 | 6.85 | 14.41 | 8.286 |
EBIT 1 | 1.873 | 3.057 | 6.58 | 13.45 | 6.255 |
Operating Margin | 15.34% | 21.16% | 25.83% | 25.87% | 9.24% |
Earnings before Tax (EBT) 1 | 1.745 | 2.699 | 6.203 | 12.58 | 4.966 |
Net income 1 | 1.168 | 1.901 | 4.602 | 9.559 | 2.504 |
Net margin | 9.57% | 13.16% | 18.06% | 18.39% | 3.7% |
EPS 2 | 0.001172 | 0.001908 | 0.004619 | 0.0120 | 0.002817 |
Free Cash Flow | - | 3.131 | 7.31 | 3.998 | -7.754 |
FCF margin | - | 21.67% | 28.69% | 7.69% | -11.45% |
FCF Conversion (EBITDA) | - | 96.36% | 106.72% | 27.75% | - |
FCF Conversion (Net income) | - | 164.68% | 158.85% | 41.82% | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 12/8/22 | 12/8/22 | 12/8/22 | 4/30/24 | 4/30/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 4.86 | 4.81 | 6.81 | 14.9 | - |
Net Cash position 1 | - | - | - | - | 12.8 |
Leverage (Debt/EBITDA) | 2.412 x | 1.48 x | 0.9943 x | 1.034 x | - |
Free Cash Flow | - | 3.13 | 7.31 | 4 | -7.75 |
ROE (net income / shareholders' equity) | - | 44.2% | 72.2% | 83% | 6.3% |
ROA (Net income/ Total Assets) | - | 12.8% | 16.6% | 20.8% | 5.3% |
Assets 1 | - | 14.85 | 27.65 | 45.99 | 47.24 |
Book Value Per Share 2 | 0 | 0 | 0.0100 | 0.0200 | 0.0600 |
Cash Flow per Share 2 | 0 | 0 | 0.0100 | 0.0100 | 0.0100 |
Capex 1 | 0.53 | 0.53 | 3.01 | 7.04 | 16.3 |
Capex / Sales | 4.33% | 3.65% | 11.82% | 13.54% | 24.1% |
Announcement Date | 12/8/22 | 12/8/22 | 12/8/22 | 4/30/24 | 4/30/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-33.33% | 57.42M | |
-23.55% | 505M | |
+33.21% | 458M | |
-21.82% | 427M | |
-5.60% | 259M | |
-22.40% | 98.1M | |
-1.64% | 87.25M | |
-3.12% | 81.16M | |
-20.69% | 58.99M | |
-3.85% | 59.43M |
- Stock Market
- Equities
- DCHCARE Stock
- Financials DC Healthcare Holdings